p53 mutations in nasal natural killer/t-cell lymphoma from mexico: Association with large cell morphology and advanced disease

American Journal of Pathology

Volumn 159, Issue 6, 2001, Pages 2095-2105

  Quintanilla Martinez, Leticia ^a   Kremer, Marcus ^a   Keller, Gisela ^b   Nathrath, Michaela ^a   Gamboa Dominguez, Armando ^c   Meneses, Abelardo ^d   Luna Contreras, Lourdes ^d   Cabras, Antonello ^a   Hoefler, Heinz ^a   Mohar, Alejandro ^d   Fend, Falko ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Technical University   (Germany)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^d INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CELL SIZE; CELL STRUCTURE; CELL TRANSFORMATION; CHROMOSOME 17P; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EXON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MEXICO; NATURAL KILLER CELL; NOSE TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURVIVAL TIME; T CELL LYMPHOMA; TUMOR SUPPRESSOR GENE;

EID: 0035180449     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63061-1     Document Type: Article

References (53)

1. Nasal and nasal-type NK/T cell lymphoma: A unique form of lymphoma associated with the Epstein-Barr virus
2. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Definitions, differential diagnosis, and epidemiology
3. Nonnasal lymphomas expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm
4. Immunophenotypic analysis of non-Hodgkin’s lymphomas in Chinese: A study of 75 cases in Hong Kong
5. Clinicopathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight year period
6. Nation-wide study of lethal mid-line granuloma in Japan: Frequencies of Wegener’s granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions
7. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and EpsteinBarr virus infection
8. Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico
9. Sinonasal NK/T-cell lymphomas in the United States
10. Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus
11. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract
12. Expression of natural killer cell markers in non-Hodgkin’s lymphomas
13. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues
14. Aggressive NK cell lymphomas: Insights into the spectrum of NK cell derived malignancies
15. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: High prevalence of p53 overexpression
16. Extranodal NK/T cell lymphoma, Nasal type
17. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
18. Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection
19. DNA mutation detection using denaturing high performance liquid chromatography (DHPLC)
20. Denaturing high pressure liquid chromatography (DHPLC) for the analysis of somatic p53 mutations
21. Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism
22. p53, the cellular gatekeeper for growth and division
23. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia
24. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations
25. Post-thymic T-cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations
26. Mutations of the p53 gene in nasal NK/T-cell lymphoma
27. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
28. Blind analysis of denaturing high performance liquid chromatography as a tool for mutation detection
29. A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC
30. Signature-based analysis of met proto-oncogene mutations using DHPLC
31. DHPLC mutation analysis of the hereditary nonpolyposis colon cancer (HNPCC) genes hMLH1 and hMSH2
32. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin’s lymphoma and their relationship to p53 status: A p53+, MDM2-, p21- immunophenotype associated with missense p53 mutations
33. p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin’s lymphomas: A potential marker of p53 tumor-suppressor gene function
34. Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma
35. Accumulation of p53 in infectious mononucleosis tissues
36. Expression of p53 protein in Tand natural killer cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations
37. EBNA-5 an Epstein-Barr virus nuclear antigen, binds to the retinoblastoma and p53 proteins
38. Stable expression of Epstein-Barr virus BZLF-1-encoded ZEBRA protein activates p53-dependent transcription in human Jurkat T-lymphoblastoid cells
39. Functional and physical interaction between p53 and BZLF1: Implications for Epstein-Barr virus tatency
40. Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-κB
41. Consistent patterns of allelic loss in natural killer cell lymphoma
42. p53 mutation is associated with progression in follicular lymphomas
43. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphoma
44. Sinonasal lymphoma. A clinicopathologic analysis of 58 cases from the Massachusetts general hospital
45. Angiocentric nasal T/natural killer cell lymphoma: A single centre study of prognostic factors in 108 patients
46. Primary nasal and nasopharyngeal lymphomas: A comparative study of clinical presentation and treatment outcome
47. Primary non-Hodgkin’s lymphoma of the nasal cavity: Prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy
48. Primary non-Hodgkin’s lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients
49. Lymphoma of the nasal cavity and paranasal sinuses: Improved outcome and altered prognostic factors with combined modality therapy
50. Cancer of the nasal cavity and paranasal sinuses. A clinico-pathological study of 277 patients
51. Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese
52. Nasal lymphoma: Results of local radiotherapy with or without chemotherapy
53. Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment